Additionally, treatment with 6-gingerol resulted in a significant influx of tumor-infiltrating lymphocytes such as CD4 and CD8 T-cells, as well as B220+ B-cells, into the tumor microenvironment and this effect can play a role in the anticancer effect of 6-gingerol. This evidence concerns the gene CD8A and neoplasm.